Brain, Vol. 126, No. 5, 1048-1057,
May 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg107
cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity
1 Department of Neurology, Medical University of Lodz, Lodz, Poland, 2 Serono Research Institute, Geneva, Switzerland and 3 Departments of Pathology (Neuropathology) and Neurology, Albert Einstein College of Medicine, New York, USA
Correspondence to: Krzysztof W. Selmaj, MD, PhD, Department of Neurology, Medical University of Lodz, Kopcinskiego Street 22, 90–153 Lodz, Poland E-mail: kselmaj{at}afazja.am.lodz.pl
cDNA microarray analysis of the regions of pathologically proven different activity of multiple sclerosis lesions was performed. Major differences in gene expression (DGE) occurred between the lesion margin and lesion centre in active lesions studied (57 and 69 genes differentially expressed, respectively), whereas the margins and centres of silent lesions showed markedly reduced heterogeneity (only 11 and two genes differentially expressed, respectively). To compare differences between chronic active and silent lesions, we performed DGE comparison of the pooled data from both types of lesions. The major DGE occurred at the lesion margin, 156 (26; 5%), the greater number representing upregulated genes at the margin of active lesions (15%). Fourteen genes were found to be significantly upregulated in marginal versus central zones in active lesions examined. These genes comprised predominantly inflammation/immune-related factors. We also performed DGE analysis of pooled genes upregulated at the margin of active lesions and found that among the 50 genes showing differences, nine out of 14 were identified in the previous analysis of overlapping differentially expressed genes. Thus this microarray analysis has identified a novel set of genes associated with lesion activity in multiple sclerosis, many of them not previously linked with the disease.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Olesen, M. G Baker, T. Freund, M. di Luca, J. Mendlewicz, I. Ragan, and M. Westphal Consensus document on European brain research J. Neurol. Neurosurg. Psychiatry, August 1, 2006; 77(suppl_1): i1 - i49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Lin, A. Kemper, J. L. Dupree, H. P. Harding, D. Ron, and B. Popko Interferon-{gamma} inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress Brain, May 1, 2006; 129(5): 1306 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R P Lisak, J A Benjamins, B Bealmear, B Yao, S Land, L Nedelkoska, and D Skundric Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures Multiple Sclerosis, April 1, 2006; 12(2): 149 - 168. [Abstract] [PDF]
|
|
|
|
|
|
C. Stadelmann, S. Ludwin, T. Tabira, A. Guseo, C. F. Lucchinetti, L. Leel-Ossy, A. T. Ordinario, W. Bruck, and H. Lassmann Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis Brain, May 1, 2005; 128(5): 979 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bielekova and R. Martin Development of biomarkers in multiple sclerosis Brain, July 1, 2004; 127(7): 1463 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Sun, U. Popat, G. Hutton, Y. C. Q. Zang, R. Krance, G. Carrum, G. A. Land, H. Heslop, M. Brenner, and J. Z. Zhang Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis Brain, May 1, 2004; 127(5): 996 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Bradl and R Hohlfeld Molecular pathogenesis of neuroinflammation J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1364 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Searching for Activity: Microarrays in MS Journal Watch Neurology, July 24, 2003; 2003(724): 6 - 6. [Full Text]
|
|